CeraVe aims to improve dermatological care for underserved populations

CeraVe is working alongside Massachusetts General Hospital on an initiative aimed at strengthening its commitment to accessible skin health in underserved communities. 

Together, the two have established the L’Oréal Dermatological Beauty/CeraVe Endowed Chair in Global Health Dermatology. 

Designed to improve access to dermatological care for underserved communities across the globe, the inaugural incumbent chair is Esther E. Freeman, MD, PhD. 

Freeman currently serves as the director of global health dermatology at Mass General and is an associate professor of dermatology at Harvard Medical School. 

[Related: Latest Headlines in the Skin Care Category]

"At CeraVe, we believe everyone deserves access to skin health care and resources," said CeraVe global general manager Melanie Vidal. "This endowed chair exemplifies our commitment to increasing skin health access for communities who need it most. By supporting Dr. Freeman's vital work at Mass General, we can make a tangible difference in the lives of many by improving access to essential dermatological care in under-resourced settings and promoting the importance of skin health on a global scale."

Through this partnership with Mass General, CeraVe will offer resources that spearhead mentorship, research training programs and advocacy to help improve the skin health and quality of life for countless individuals globally, the groups shared. 

“I am honored to be the inaugural L'Oréal Dermatological Beauty / CeraVe Endowed Chair in Global Health Dermatology," said Dr. Freeman. "This support will be instrumental in expanding our reach, training more healthcare workers, and improving skin health outcomes for vulnerable populations around the world. The CeraVe Endowed Chair will allow us to build and support sustainable solutions for accessible skin health globally and to mentor the next generation of leaders in global health dermatology."